Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases

• Hoofdauteurs: Burcu Bozkaya Yücel (Auteur), Ozlem Aydog (Auteur), Hulya Nalcacioglu (Auteur), Ayşegül Yılmaz (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Anti-interleukin 1 agents are used successfully in colchicine-resistant or intolerant Familial Mediterranean Fever (FMF) patients. Sixty-five patients with FMF who received canakinumab treatment for at least 6 months due to colchicine resistance or intolerance between 2016 and 2020 in our department...